Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01354
|
|||||
| Drug Name |
Nogalamycin
|
|||||
| Synonyms |
AC1MBPR2
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Cancer [ICD11: 2A00-2F9Z] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C39H49NO16
|
|||||
| Canonical SMILES |
CC1C(C(C(C(O1)OC2CC(C(C3=CC4=C(C(=C23)O)C(=O)C5=C(C=C6C(=C5C4=O)OC7C(C(C(C6(O7)C)O)N(C)C)O)O)C(=O)OC)(C)O)OC)(C)OC)OC
|
|||||
| InChI |
InChI=1S/C39H49NO16/c1-14-32(49-7)39(4,52-10)33(50-8)36(53-14)54-19-13-37(2,48)24(34(47)51-9)15-11-16-21(27(43)20(15)19)28(44)22-18(41)12-17-30(23(22)26(16)42)55-35-29(45)25(40(5)6)31(46)38(17,3)56-35/h11-12,14,19,24-25,29,31-33,35-36,41,43,45-46,48H,13H2,1-10H3/t14-,19-,24-,25-,29-,31+,32-,33-,35+,36-,37-,38+,39+/m0/s1
|
|||||
| InChIKey |
KGTDRFCXGRULNK-JYOBTZKQSA-N
|
|||||
| CAS Number |
CAS 1404-15-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 787.8 | Topological Polar Surface Area | 229 | ||
| Heavy Atom Count | 56 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 17 | |||
| XLogP |
1.1
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Wikipedia: Nogalamycin | |||||
| 2 | Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors. Bioorg Med Chem. 2012 Sep 15;20(18):5388-95. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.